相关实验视频

Updated: Jun 7, 2025

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

通过NOX4的调节,GRK2通过调节西斯普拉丁诱导的急性肝损伤

Qianlei Wang¹, Mengyang Li¹, Fei Duan¹

¹Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Center of Rheumatoid Arthritis of Anhui Medical University, Hefei, 230032, China.

Cell biology and toxicology

|November 15, 2024

概括

G蛋白结合受体激酶2 (GRK2) 通过增加氧化应激和内质网膜应激,驱动着西斯胺诱导的急性肝损伤 (ALI). 抑制GRK2可以保护肝脏免受损伤,这表明GRK2是治疗点.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
药理学药理学是指药理学的学科.

背景情况:

由西斯普拉丁诱导的急性肝损伤 (ALI) 构成了重大的临床挑战.
在ALI病变发生过程中,G蛋白结合受体激酶2 (GRK2) 的作用尚未完全被理解.

研究的目的:

调查GRK2在西斯普拉丁诱导的ALI中的作用.
评估ALI中药理GRK2抑制的保护作用.

主要方法:

在半双型GRK2 (Grk2±) 和野生型 (WT) 小鼠中生成ALI模型.
使用生物化学参数和组织病理学评估肝损伤.
在体外和体内使用GRK2-siRNA和药理抑制剂 (CP-25,帕洛).

主要成果:

西斯普拉丁增加了GRK2,p-GRK2和NADPH氧化酶4 (NOX4) 的表达,导致AST/ALT升高,氧化应激,ER应激和亡.
在Grk2±小鼠中,GRK2抑制显著降低了肝损伤标志物,NOX4水平,ER压力和亡.
在体外研究证实了GRK2抑制对西斯普拉丁诱导的细胞损伤的保护作用.

结论:

通过调节NOX4和ER应激通路,GRK2通过调节西斯普拉丁诱导的ALI.
药理上抑制GRK2有效缓解肝损伤.
GRK2代表了预防和治疗肝损伤的有前途的治疗标.

关键词:

西斯普拉丁 (Cisplatin) 是一种细胞内膜网膜应激压力格鲁吉亚克朗2格鲁吉亚克朗2 肝脏损伤肝脏损伤是什么?在NOX4中,NOX4是

更多相关视频

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...